Docetaxel and Continuous-Infusion Fluorouracil Versus Epirubicin, Cisplatin, and Fluorouracil for Advanced Gastric Adenocarcinoma: A Randomized Phase II StudyPeter Thuss‐Patience, Peter Reichardt, Dirk Hennesser et al.|Journal of Clinical Oncology|2005Cited by 114
Docetaxel and 5-FU continuous infusion (DF) versus epirubicin, cisplatin and 5-FU (ECF) for advanced gastric adenocarcinoma; a randomized phase II studyP. Thuss-Patience, Peter Reichardt, Albrecht Kretzschmar et al.|European Journal of Cancer|2001Cited by 2